1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alzheimer Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Monoamine Oxidase 1.2.3 Pain Inhibitor (acetylcholinesterase) 1.2.4 Glutamate Inhibitor 1.3 Market by Application 1.3.1 Global Alzheimer Disease Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Alzheimer Disease Treatment Market Size (2017-2028) 2.2 Alzheimer Disease Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Alzheimer Disease Treatment Market Size by Region (2017-2022) 2.4 Global Alzheimer Disease Treatment Market Size Forecast by Region (2023-2028) 2.5 Global Top Alzheimer Disease Treatment Countries Ranking by Market Size 3 Alzheimer Disease Treatment Competitive by Company 3.1 Global Alzheimer Disease Treatment Revenue by Players 3.1.1 Global Alzheimer Disease Treatment Revenue by Players (2017-2022) 3.1.2 Global Alzheimer Disease Treatment Market Share by Players (2017-2022) 3.2 Global Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Alzheimer Disease Treatment Revenue 3.4 Global Alzheimer Disease Treatment Market Concentration Ratio 3.4.1 Global Alzheimer Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Disease Treatment Revenue in 2021 3.5 Global Alzheimer Disease Treatment Key Players Head office and Area Served 3.6 Key Players Alzheimer Disease Treatment Product Solution and Service 3.7 Date of Enter into Alzheimer Disease Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Alzheimer Disease Treatment Breakdown Data by Type 4.1 Global Alzheimer Disease Treatment Historic Revenue by Type (2017-2022) 4.2 Global Alzheimer Disease Treatment Forecasted Revenue by Type (2023-2028) 5 Global Alzheimer Disease Treatment Breakdown Data by Application 5.1 Global Alzheimer Disease Treatment Historic Market Size by Application (2017-2022) 5.2 Global Alzheimer Disease Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Alzheimer Disease Treatment Revenue by Company (2020-2022) 6.2 North America Alzheimer Disease Treatment Revenue by Type (2017-2028) 6.3 North America Alzheimer Disease Treatment Revenue by Application (2017-2028) 6.4 North America Alzheimer Disease Treatment Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Alzheimer Disease Treatment Revenue by Company (2020-2022) 7.2 Europe Alzheimer Disease Treatment Revenue by Type (2017-2028) 7.3 Europe Alzheimer Disease Treatment Revenue by Application (2017-2028) 7.4 Europe Alzheimer Disease Treatment Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Alzheimer Disease Treatment Revenue by Company (2020-2022) 8.2 Asia Pacific Alzheimer Disease Treatment Revenue by Type (2017-2028) 8.3 Asia Pacific Alzheimer Disease Treatment Revenue by Application (2017-2028) 8.4 Asia Pacific Alzheimer Disease Treatment Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Alzheimer Disease Treatment Revenue by Company (2020-2022) 9.2 Latin America Alzheimer Disease Treatment Revenue by Type (2017-2028) 9.3 Latin America Alzheimer Disease Treatment Revenue by Application (2017-2028) 9.4 Latin America Alzheimer Disease Treatment Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Alzheimer Disease Treatment Revenue by Company (2020-2022) 10.2 Middle East and Africa Alzheimer Disease Treatment Revenue by Type (2017-2028) 10.3 Middle East and Africa Alzheimer Disease Treatment Revenue by Application (2017-2028) 10.4 Middle East and Africa Alzheimer Disease Treatment Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Allergan Business Overview 11.1.3 Allergan Alzheimer Disease Treatment Products and Services 11.1.4 Allergan Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.1.5 Allergan Alzheimer Disease Treatment SWOT Analysis 11.1.6 Allergan Recent Developments 11.2 Eisai 11.2.1 Eisai Company Details 11.2.2 Eisai Business Overview 11.2.3 Eisai Alzheimer Disease Treatment Products and Services 11.2.4 Eisai Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.2.5 Eisai Alzheimer Disease Treatment SWOT Analysis 11.2.6 Eisai Recent Developments 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Alzheimer Disease Treatment Products and Services 11.3.4 Novartis Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.3.5 Novartis Alzheimer Disease Treatment SWOT Analysis 11.3.6 Novartis Recent Developments 11.4 Teva Pharmaceutical Industries 11.4.1 Teva Pharmaceutical Industries Company Details 11.4.2 Teva Pharmaceutical Industries Business Overview 11.4.3 Teva Pharmaceutical Industries Alzheimer Disease Treatment Products and Services 11.4.4 Teva Pharmaceutical Industries Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.4.5 Teva Pharmaceutical Industries Alzheimer Disease Treatment SWOT Analysis 11.4.6 Teva Pharmaceutical Industries Recent Developments 11.5 Amgen 11.5.1 Amgen Company Details 11.5.2 Amgen Business Overview 11.5.3 Amgen Alzheimer Disease Treatment Products and Services 11.5.4 Amgen Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.5.5 Amgen Alzheimer Disease Treatment SWOT Analysis 11.5.6 Amgen Recent Developments 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Alzheimer Disease Treatment Products and Services 11.6.4 Pfizer Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.6.5 Pfizer Alzheimer Disease Treatment SWOT Analysis 11.6.6 Pfizer Recent Developments 11.7 UCB 11.7.1 UCB Company Details 11.7.2 UCB Business Overview 11.7.3 UCB Alzheimer Disease Treatment Products and Services 11.7.4 UCB Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.7.5 UCB Alzheimer Disease Treatment SWOT Analysis 11.7.6 UCB Recent Developments 11.8 H. Lundbeck 11.8.1 H. Lundbeck Company Details 11.8.2 H. Lundbeck Business Overview 11.8.3 H. Lundbeck Alzheimer Disease Treatment Products and Services 11.8.4 H. Lundbeck Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.8.5 H. Lundbeck Alzheimer Disease Treatment SWOT Analysis 11.8.6 H. Lundbeck Recent Developments 11.9 F. Hoffmann-La Roche 11.9.1 F. Hoffmann-La Roche Company Details 11.9.2 F. Hoffmann-La Roche Business Overview 11.9.3 F. Hoffmann-La Roche Alzheimer Disease Treatment Products and Services 11.9.4 F. Hoffmann-La Roche Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.9.5 F. Hoffmann-La Roche Alzheimer Disease Treatment SWOT Analysis 11.9.6 F. Hoffmann-La Roche Recent Developments 11.10 Eli Lilly 11.10.1 Eli Lilly Company Details 11.10.2 Eli Lilly Business Overview 11.10.3 Eli Lilly Alzheimer Disease Treatment Products and Services 11.10.4 Eli Lilly Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.10.5 Eli Lilly Alzheimer Disease Treatment SWOT Analysis 11.10.6 Eli Lilly Recent Developments 11.11 Ono Pharmaceutical 11.11.1 Ono Pharmaceutical Company Details 11.11.2 Ono Pharmaceutical Business Overview 11.11.3 Ono Pharmaceutical Alzheimer Disease Treatment Products and Services 11.11.4 Ono Pharmaceutical Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.11.5 Ono Pharmaceutical Recent Developments 11.12 Johnson & Johnson 11.12.1 Johnson & Johnson Company Details 11.12.2 Johnson & Johnson Business Overview 11.12.3 Johnson & Johnson Alzheimer Disease Treatment Products and Services 11.12.4 Johnson & Johnson Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.12.5 Johnson & Johnson Recent Developments 11.13 Daiichi Sankyo 11.13.1 Daiichi Sankyo Company Details 11.13.2 Daiichi Sankyo Business Overview 11.13.3 Daiichi Sankyo Alzheimer Disease Treatment Products and Services 11.13.4 Daiichi Sankyo Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.13.5 Daiichi Sankyo Recent Developments 11.14 Merz Pharma 11.14.1 Merz Pharma Company Details 11.14.2 Merz Pharma Business Overview 11.14.3 Merz Pharma Alzheimer Disease Treatment Products and Services 11.14.4 Merz Pharma Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) 11.14.5 Merz Pharma Recent Developments 12 Alzheimer Disease Treatment Market Dynamics 12.1 Alzheimer Disease Treatment Market Trends 12.2 Alzheimer Disease Treatment Market Drivers 12.3 Alzheimer Disease Treatment Market Challenges 12.4 Alzheimer Disease Treatment Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Alzheimer Disease Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Monoamine Oxidase Table 3. Key Players of Pain Inhibitor (acetylcholinesterase) Table 4. Key Players of Glutamate Inhibitor Table 5. Global Alzheimer Disease Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Alzheimer Disease Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 7. Global Alzheimer Disease Treatment Revenue by Region (2017-2022) & (US$ Million) Table 8. Global Alzheimer Disease Treatment Revenue Market Share by Region (2017-2022) Table 9. Global Alzheimer Disease Treatment Revenue by Players (2017-2022) & (US$ Million) Table 10. Global Alzheimer Disease Treatment Market Share by Players (2017-2022) Table 11. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Disease Treatment as of 2021) Table 12. Ranking of Global Top Alzheimer Disease Treatment Companies by Revenue (US$ Million) in 2021 Table 13. Global 5 Largest Players Market Share by Alzheimer Disease Treatment Revenue (CR5 and HHI) & (2017-2022) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Alzheimer Disease Treatment Product Solution and Service Table 16. Date of Key Manufacturers Enter into Alzheimer Disease Treatment Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Alzheimer Disease Treatment Market Size by Type (2017-2022) & (US$ Million) Table 19. Global Alzheimer Disease Treatment Revenue Market Share by Type (2017-2022) Table 20. Global Alzheimer Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 21. Global Alzheimer Disease Treatment Revenue Market Share by Type (2023-2028) Table 22. Global Alzheimer Disease Treatment Market Size by Application (2017-2022) & (US$ Million) Table 23. Global Alzheimer Disease Treatment Revenue Market Share by Application (2017-2022) Table 24. Global Alzheimer Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 25. Global Alzheimer Disease Treatment Revenue Market Share by Application (2023-2028) Table 26. North America Alzheimer Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 27. North America Alzheimer Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 28. North America Alzheimer Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 29. North America Alzheimer Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 30. North America Alzheimer Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 31. North America Alzheimer Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 32. North America Alzheimer Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 33. Europe Alzheimer Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 34. Europe Alzheimer Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 35. Europe Alzheimer Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 36. Europe Alzheimer Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 37. Europe Alzheimer Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 38. Europe Alzheimer Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 39. Europe Alzheimer Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 40. Asia Pacific Alzheimer Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 41. Asia Pacific Alzheimer Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 42. Asia Pacific Alzheimer Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 43. Asia Pacific Alzheimer Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 44. Asia Pacific Alzheimer Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 45. Asia Pacific Alzheimer Disease Treatment Revenue by Region (2017-2022) & (US$ Million) Table 46. Asia Pacific Alzheimer Disease Treatment Revenue by Region (2023-2028) & (US$ Million) Table 47. Latin America Alzheimer Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 48. Latin America Alzheimer Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 49. Latin America Alzheimer Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 50. Latin America Alzheimer Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 51. Latin America Alzheimer Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 52. Latin America Alzheimer Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 53. Latin America Alzheimer Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 54. Middle East and Africa Alzheimer Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 55. Middle East and Africa Alzheimer Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Alzheimer Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Alzheimer Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Alzheimer Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Alzheimer Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Alzheimer Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 61. Allergan Company Details Table 62. Allergan Business Overview Table 63. Allergan Alzheimer Disease Treatment Product and Services Table 64. Allergan Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 65. Allergan Alzheimer Disease Treatment SWOT Analysis Table 66. Allergan Recent Developments Table 67. Eisai Company Details Table 68. Eisai Business Overview Table 69. Eisai Alzheimer Disease Treatment Product and Services Table 70. Eisai Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 71. Eisai Alzheimer Disease Treatment SWOT Analysis Table 72. Eisai Recent Developments Table 73. Novartis Company Details Table 74. Novartis Business Overview Table 75. Novartis Alzheimer Disease Treatment Product and Services Table 76. Novartis Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 77. Novartis Alzheimer Disease Treatment SWOT Analysis Table 78. Novartis Recent Developments Table 79. Teva Pharmaceutical Industries Company Details Table 80. Teva Pharmaceutical Industries Business Overview Table 81. Teva Pharmaceutical Industries Alzheimer Disease Treatment Product and Services Table 82. Teva Pharmaceutical Industries Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 83. Teva Pharmaceutical Industries Alzheimer Disease Treatment SWOT Analysis Table 84. Teva Pharmaceutical Industries Recent Developments Table 85. Amgen Company Details Table 86. Amgen Business Overview Table 87. Amgen Alzheimer Disease Treatment Product and Services Table 88. Amgen Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 89. Amgen Alzheimer Disease Treatment SWOT Analysis Table 90. Amgen Recent Developments Table 91. Pfizer Company Details Table 92. Pfizer Business Overview Table 93. Pfizer Alzheimer Disease Treatment Product and Services Table 94. Pfizer Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 95. Pfizer Alzheimer Disease Treatment SWOT Analysis Table 96. Pfizer Recent Developments Table 97. UCB Company Details Table 98. UCB Business Overview Table 99. UCB Alzheimer Disease Treatment Product and Services Table 100. UCB Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 101. UCB Alzheimer Disease Treatment SWOT Analysis Table 102. UCB Recent Developments Table 103. H. Lundbeck Company Details Table 104. H. Lundbeck Business Overview Table 105. H. Lundbeck Alzheimer Disease Treatment Product and Services Table 106. H. Lundbeck Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 107. H. Lundbeck Alzheimer Disease Treatment SWOT Analysis Table 108. H. Lundbeck Recent Developments Table 109. F. Hoffmann-La Roche Company Details Table 110. F. Hoffmann-La Roche Business Overview Table 111. F. Hoffmann-La Roche Alzheimer Disease Treatment Product and Services Table 112. F. Hoffmann-La Roche Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 113. F. Hoffmann-La Roche Alzheimer Disease Treatment SWOT Analysis Table 114. F. Hoffmann-La Roche Recent Developments Table 115. Eli Lilly Company Details Table 116. Eli Lilly Business Overview Table 117. Eli Lilly Alzheimer Disease Treatment Product and Services Table 118. Eli Lilly Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 119. Eli Lilly Alzheimer Disease Treatment SWOT Analysis Table 120. Eli Lilly Recent Developments Table 121. Ono Pharmaceutical Company Details Table 122. Ono Pharmaceutical Business Overview Table 123. Ono Pharmaceutical Alzheimer Disease Treatment Product and Services Table 124. Ono Pharmaceutical Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 125. Ono Pharmaceutical Recent Developments Table 126. Johnson & Johnson Company Details Table 127. Johnson & Johnson Business Overview Table 128. Johnson & Johnson Alzheimer Disease Treatment Product and Services Table 129. Johnson & Johnson Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 130. Johnson & Johnson Recent Developments Table 131. Daiichi Sankyo Company Details Table 132. Daiichi Sankyo Business Overview Table 133. Daiichi Sankyo Alzheimer Disease Treatment Product and Services Table 134. Daiichi Sankyo Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 135. Daiichi Sankyo Recent Developments Table 136. Merz Pharma Company Details Table 137. Merz Pharma Business Overview Table 138. Merz Pharma Alzheimer Disease Treatment Product and Services Table 139. Merz Pharma Alzheimer Disease Treatment Revenue in Alzheimer Disease Treatment Business (2017-2022) & (US$ Million) Table 140. Merz Pharma Recent Developments Table 141. Alzheimer Disease Treatment Market Trends Table 142. Alzheimer Disease Treatment Market Drivers Table 143. Alzheimer Disease Treatment Market Challenges Table 144. Alzheimer Disease Treatment Market Restraints Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Alzheimer Disease Treatment Sales Market Share by Type: 2021 VS 2028 Figure 2. Monoamine Oxidase Features Figure 3. Pain Inhibitor (acetylcholinesterase) Features Figure 4. Glutamate Inhibitor Features Figure 5. Global Alzheimer Disease Treatment Sales Market Share by Application: 2021 VS 2028 Figure 6. Hospital Pharmacy Case Studies Figure 7. Retail Pharmacy Case Studies Figure 8. Online Sales Case Studies Figure 9. Alzheimer Disease Treatment Report Years Considered Figure 10. Global Alzheimer Disease Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Alzheimer Disease Treatment Market Size 2017-2028 (US$ Million) Figure 12. Global Alzheimer Disease Treatment Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global Alzheimer Disease Treatment Revenue Market Share by Region in 2017 VS 2022 Figure 14. Global Top 10 Alzheimer Disease Treatment Countries Ranking by Market Size (US$ Million) in 2021 Figure 15. Global Alzheimer Disease Treatment Market Share by Players in 2021 Figure 16. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Disease Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Alzheimer Disease Treatment Revenue in 2021 Figure 18. North America Alzheimer Disease Treatment Revenue Market Share by Company in 2021 Figure 19. North America Alzheimer Disease Treatment Revenue Market Share by Type (2017-2028) Figure 20. North America Alzheimer Disease Treatment Revenue Market Share by Application (2017-2028) Figure 21. North America Alzheimer Disease Treatment Revenue Share by Country (2017-2028) Figure 22. U.S. Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 23. Canada Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 24. Europe Alzheimer Disease Treatment Revenue Market Share by Company in 2021 Figure 25. Europe Alzheimer Disease Treatment Revenue Market Share by Type (2017-2028) Figure 26. Europe Alzheimer Disease Treatment Revenue Market Share by Application (2017-2028) Figure 27. Europe Alzheimer Disease Treatment Revenue Share by Country (2017-2028) Figure 28. Germany Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 29. France Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 30. U.K. Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 31. Italy Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 32. Russia Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 33. Asia Pacific Alzheimer Disease Treatment Revenue Market Share by Company in 2021 Figure 34. Asia Pacific Alzheimer Disease Treatment Revenue Market Share by Type (2017-2028) Figure 35. Asia Pacific Alzheimer Disease Treatment Revenue Market Share by Application (2017-2028) Figure 36. Asia Pacific Alzheimer Disease Treatment Revenue Share by Region (2017-2028) Figure 37. China Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 38. Japan Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 39. South Korea Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 40. India Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 41. Australia Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 42. Taiwan Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 43. Indonesia Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 44. Thailand Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 45. Malaysia Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 46. Philippines Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 47. Vietnam Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 48. Latin America Alzheimer Disease Treatment Revenue Market Share by Company in 2021 Figure 49. Latin America Alzheimer Disease Treatment Revenue Market Share by Type (2017-2028) Figure 50. Latin America Alzheimer Disease Treatment Revenue Market Share by Application (2017-2028) Figure 51. Latin America Alzheimer Disease Treatment Revenue Share by Country (2017-2028) Figure 52. Mexico Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 53. Brazil Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 54. Argentina Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 55. Middle East and Africa Alzheimer Disease Treatment Revenue Market Share by Company in 2021 Figure 56. Middle East and Africa Alzheimer Disease Treatment Revenue Market Share by Type (2017-2028) Figure 57. Middle East and Africa Alzheimer Disease Treatment Revenue Market Share by Application (2017-2028) Figure 58. Middle East and Africa Alzheimer Disease Treatment Revenue Share by Country (2017-2028) Figure 59. Turkey Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 60. Saudi Arabia Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 61. UAE Alzheimer Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 62. Allergan Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 63. Eisai Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 64. Novartis Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 66. Amgen Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 67. Pfizer Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 68. UCB Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 69. H. Lundbeck Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 70. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 71. Eli Lilly Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 72. Ono Pharmaceutical Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 73. Johnson & Johnson Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 74. Daiichi Sankyo Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 75. Merz Pharma Revenue Growth Rate in Alzheimer Disease Treatment Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Allergan Eisai Novartis Teva Pharmaceutical Industries Amgen Pfizer UCB H. Lundbeck F. Hoffmann-La Roche Eli Lilly Ono Pharmaceutical Johnson & Johnson Daiichi Sankyo Merz Pharma